CSL Limited

07/04/2024 | Press release | Distributed by Public on 07/04/2024 01:13

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe